MeSH D004415 - dyspepsia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Salix Pharmaceuticals | Famotidine | Pepcid |  | 1987-02-02 |  |  |
| Teva | Cimetidine | Cimetidine |  | 1994-05-17 |  |  |
| Famotidine | Famotidine |  | 2001-04-16 |  |  | |
| Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-10-29 |  |  | |
| Glenmark Pharmaceuticals | Famotidine | Famotidine |  | 2005-03-07 |  |  |
| Mylan | Cimetidine | Cimetidine |  | 1994-05-17 |  |  |
| Famotidine | Famotidine |  | 2001-04-18 |  |  | |
| NATCO Pharma | Famotidine | Famotidine |  | 2001-12-21 |  |  |
| Johnson & Johnson | Famotidine | Pepcid Ac |  | 1995-04-28 |  |  |
| Famotidine | Pepcid Complete |  | 2000-10-16 |  |  | |
| Perrigo | Cimetidine | Cimetidine |  | 1998-06-19 |  |  |
| Famotidine | Famotidine |  | 2005-03-18 |  |  | |
| Famotidine | Famotidine, Carbonate, Magnesium Hydroxide |  | 2008-02-06 |  |  | |
| P&L Developments (PLD) | Famotidine | Famotidine |  | 2001-07-26 |  |  |
| GSK | Cimetidine | Tagamet |  | 1982-01-01 |  |  |
| Lupin Research | Famotidine | Famotidine |  | 2010-06-29 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%7/7
Phase 2
56%10/18
Phase 3
33%13/39
Approved: 6Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use